Panacos Pharmaceuticals, Inc. (PANC)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 4, 2025
Panacos Pharmaceuticals Market Cap
Panacos Pharmaceuticals has a market cap or net worth of $54 as of January 23, 2026. Its market cap has decreased by -98.99% in one year.
Market Cap
54.00
Enterprise Value
n/a
Revenue
99.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 14, 2005, Panacos Pharmaceuticals's market cap has decreased from 4.35M to 54.00, a decrease of -100.00%. That is a compound annual growth rate of -42.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 54.00 | - |
| Dec 4, 2024 | 54.00 | - |
| Dec 21, 2023 | 54.00 | - |
| Dec 31, 2021 | 54.00 | -99.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| American Oriental Bioengineering | 88.00 |
| RenovaCare | 87.00 |
| Cardax | 83.00 |
| Bioasis Technologies | 79.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |